Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.210
+0.110 (5.24%)
At close: Feb 21, 2025, 4:00 PM
2.260
+0.050 (2.26%)
After-hours: Feb 21, 2025, 7:47 PM EST
Company Description
Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions.
The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse.
It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.
Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Intelligent Bio Solutions Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 50 |
| CEO | Harry Simeonidis |
Contact Details
Address: 135 West, 41ST Street, 5th Floor New York, New York 10036 United States | |
| Phone | 646 828 8258 |
| Website | ibs.inc |
Stock Details
| Ticker Symbol | INBS |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001725430 |
| CUSIP Number | 36151G600 |
| ISIN Number | US36151G6008 |
| Employer ID | 82-1512711 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Harry Simeonidis | President and Chief Executive Officer |
| Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law | Chief Financial Officer |
| Alex Arzeno | Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Feb 21, 2025 | 8-K | Current Report |
| Feb 21, 2025 | 424B5 | Filing |
| Feb 20, 2025 | 424B5 | Filing |
| Feb 19, 2025 | 424B5 | Filing |
| Feb 13, 2025 | 8-K | Current Report |
| Feb 13, 2025 | 10-K/A | [Amend] Annual report |
| Feb 13, 2025 | 10-Q | Quarterly Report |
| Feb 10, 2025 | 8-K | Current Report |
| Feb 7, 2025 | 8-K | Current Report |
| Feb 6, 2025 | 8-K | Current Report |